Categories Multiple Myeloma

Pomalidomide in Refractory Multiple Myeloma

Pomalidomide in Refractory Multiple Myeloma

In this segment, Noopur Raje, MD, Sagar Lonial, MD, and Ann McNeill, RN, APN, discuss the role of pomalidomide in therapy for patients with multiple myeloma, as well as the toxicities and adverse reactions associated with pomalidomide therapy.

Get more expert insight, at http://www.onclive.com/insights/myeloma

Leave a Reply

Your email address will not be published. Required fields are marked *